Literature DB >> 16452475

Tumor necrosis factor receptor (TNFR)-associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells.

Edward M Esparza1, Tullia Lindsten, Julia M Stockhausen, Robert H Arch.   

Abstract

Tumor necrosis factor receptor (TNFR) family members such as glucocorticoid-induced TNFR (GITR) control T cell activation, differentiation, and effector functions. Importantly, GITR functions as a pivotal regulator of physiologic and pathologic immune responses by abrogating the suppressive effects of T regulatory cells and costimulating T effector cells. However, the molecular mechanisms underlying GITR-triggered signal transduction pathways remain unclear. Interestingly, GITR-induced stimulation of TNFR-associated factor (TRAF) 5-deficient T cells resulted in decreased activation of nuclear factor kappaB as well as the mitogen-activated protein kinases p38 and extracellular signal-regulated protein kinase, whereas activation of c-Jun N-terminal kinase was less affected. Consistent with impaired signaling, costimulatory effects of GITR were diminished in TRAF5-/- T cells. In sum, our studies indicate that TRAF5 plays a crucial role in GITR-induced signaling pathways that augment T cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452475     DOI: 10.1074/jbc.M512915200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.

Authors:  Hiroyuki Nagashima; Yuko Okuyama; Atsuko Asao; Takeshi Kawabe; Satoshi Yamaki; Hiroyasu Nakano; Michael Croft; Naoto Ishii; Takanori So
Journal:  Nat Immunol       Date:  2014-03-30       Impact factor: 25.606

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.

Authors:  Eun Jee Kim; Jae Geun Lee; Joon Ye Kim; Seung Hwan Song; Dong Jin Joo; Kyu Ha Huh; Myoung Soo Kim; Beom Seok Kim; Yu Seun Kim
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

Review 4.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

Review 5.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  NGF-promoted axon growth and target innervation requires GITRL-GITR signaling.

Authors:  Gerard W O'Keeffe; Humberto Gutierrez; Pier Paolo Pandolfi; Carlo Riccardi; Alun M Davies
Journal:  Nat Neurosci       Date:  2008-01-06       Impact factor: 24.884

7.  Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.

Authors:  Zhaocai Zhou; Xiaomin Song; Alan Berezov; Geng Zhang; Yanjing Li; Hongtao Zhang; Ramachandran Murali; Bin Li; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

8.  TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection.

Authors:  Zachary J Kraus; Jodie S Haring; Gail A Bishop
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression.

Authors:  Xiuwen Wang; Jing Yang; Lei Han; Kaixia Zhao; Qingsi Wu; Liming Bao; Zhiyuan Li; Ling Lv; Bin Li
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

Review 10.  Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists.

Authors:  Dana A Emerson; William L Redmond
Journal:  BioDrugs       Date:  2018-06       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.